Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07008417
PHASE1

A Study on Bioequivalence of Cabergoline Tablets in Human Body

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the bioequivalence of the test formulation and reference formulation of cabergoline tablets in healthy Chinese subjects under fasting and postprandial conditions.

Official title: A Single-center, Randomized, Open-label, Two-formulation, Two-cycle, Two-sequence, Single-dose, Crossover Bioequivalence Study of Cabergoline Tablets Under Fasting and Postprandial Conditions in Healthy Chinese Subjects

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2025-06-30

Completion Date

2026-05-06

Last Updated

2025-11-17

Healthy Volunteers

Yes

Interventions

DRUG

Cabergoline tablets test formulation

Single oral administration

DRUG

Cabergoline tablets reference formulation

Single oral administration

Locations (1)

Zhejiang Xiaoshan Hospital

Hangzhou, Zhejiang, China